Connect with us
Biotechnology has surged in Galicia, especially Pontevedra, now second only to Catalonia. The sector generates €1.5 billion annually, 2% of Galician GDP, with significant growth post-COVID....
Spain’s public healthcare spending rose to €97.66 billion in 2023, up 6.2%. Pharmaceutical spending hit a historic low share of 14.3% despite nominal growth. Public health...
Bioga and CESGA strengthen their 15-year collaboration to boost Galicia’s biotech sector using high-performance computing. Their joint efforts aim to cut drug development costs and time,...
A Carlos III Health Institute team showed CRISPR-based gene therapy effectively targets Ewing sarcoma in preclinical models. Using a tumor-specific promoter, the treatment avoids harming healthy...
CNIC researchers have developed a promising gene therapy for ARVC5, a lethal genetic heart disease. By delivering a healthy TMEM43 gene via AAV vectors, they improved...
Biotech stocks are currently out of favor, but analysts believe sentiment may have bottomed out, creating a buying opportunity—especially for undervalued small and mid-cap firms. Concerns...
Northwestern University researchers have created the world’s smallest, dissolvable pacemaker for critically ill newborns. Injected via syringe and activated by a chest patch using infrared light,...
The CNAG closed 2024 as a leader in precision medicine, doubling sequencing capacity and advancing diagnostics for complex diseases. It contributed to major projects, including rare...
AstraZeneca and 13 scientific societies signed a document promoting a multidisciplinary approach to cardio-renal-metabolic diseases. The agreement emphasizes early diagnosis, care coordination, research, awareness, screening, equitable...
Sylentis, part of PharmaMar Group, secured a €21.1M NextGenerationEU grant for its Syoligo project—Spain’s first RNA drug production plant. Located in Getafe, Madrid, it will focus...
 |
|
 |  |
 |
|